Survival of women with breast cancer in Austria by age, stage and period of diagnosis

Wiener Klinische Wochenschrift

Volumn 114, Issue 12, 2002, Pages 438-442

  Vutuc, Christian ^a   Waldhoer, Thomas ^a   Klimont, Jeannette ^a   Haidinger, Gerald ^a   Jakesz, Raimund ^a   Kubista, Ernst ^a   Zielinski, Christoph ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Age; Breast cancer; Stage; Survival

Indexed keywords

ADULT; AGE; ARTICLE; AUSTRIA; BREAST CANCER; CALCULATION; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CONFIDENCE INTERVAL; DIAGNOSTIC VALUE; FEMALE; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; SURVIVAL RATE; AGED; BREAST TUMOR; MASS SCREENING; MIDDLE AGED; MORTALITY; PATHOLOGY; STATISTICS; SURVIVAL;

ADULT; AGE FACTORS; AGED; AUSTRIA; BREAST NEOPLASMS; FEMALE; HUMAN; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGE; NEOPLASM STAGING; SURVIVAL ANALYSIS; HUMANS; MIDDLE AGED;

EID: 0037188777     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Prevalence of self-reported screening mammography and impact on breast cancer mortality in Austria
2. Very low-dose adjuvant chemotherapy in steroid receptor negative stage I breast cancer patients
3. Recent trends in US breast cancer incidence, survival, and mortality rates
4. Retrospective study of reasons for improved survival in patients with breast cancer in East Anglia: Earlier diagnosis or better treatment?
5. A computer program package for relative survival analysis
6. Regression analysis of relative survival rates
7. Survival of women with breast cancer in Europe: Variation with age, year of diagnosis and country
8. How many deaths have been avoided through improvements of cancer survival?
9. Long-term survival and prognostic factors in breast cancer patients with localized (no skin, muscle, or chest wall attachment) disease with and without positive lymph nodes
10. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 Randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women
11. Improvement in the prognosis of breast cancer from 1965 to 1984
12. Results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with standard dose sdoxorubicin-containing chemotherapy: A reference
13. Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer
14. Gibt es fortschritte in der medikamentösen therapie von patienten mit mammakarzinom?